Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.10
-0.43 (-6.58%)
At close: Oct 13, 2026, 4:00 PM EDT
6.10
0.00 (0.00%)
After-hours: Oct 13, 2026, 4:10 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $168.37 million as of October 13, 2026. It is the 21,521st most valuable company in the world and the 3,692nd biggest in the United States. Its market cap has increased by 154.17% in one year.
Market Cap
168.37M
Enterprise Value
108.92M
1-Year Change
154.17%
Global Rank
Country Rank
#3,692 United States
Category
ChartMarket Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $168.37M, a decrease of -80.31%. That is a compound annual growth rate of -19.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 168.37M | 68.14% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 200.93M |
| Whitehawk Therapeutics | 200.67M |
| Alpha Cognition | 196.87M |
| NervGen Pharma | 186.01M |
| Adagene | 185.32M |
| Yarrow Bioscience | 183.39M |
| PepGen | 181.46M |
| Oramed Pharmaceuticals | 180.12M |